{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:32:50Z","timestamp":1789983170532,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The effectiveness of mechanical thrombectomy (MT) in cancer-related stroke (CRS) is largely unknown. This study aims to investigate the clinical and radiological outcomes of MT in CRS patients. We also explored the factors that independently affect functional outcomes of patients with CRS after MT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively reviewed 341 patients who underwent MT after acute ischemic stroke onset between May 2014 and May 2020. We classified the patients into CRS (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200934) and control (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009307) groups and compared their clinical details. Among CRS patients, we analyzed the groups with and without good outcomes (3-months modified Rankin scale [mRS] score 0, 1, 2). Multivariate analysis was performed to investigate the independent predictors of unfavorable outcomes in patients with CRS after MT.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 341 acute ischemic stroke patients received MT, of whom 34 (9.9%) had CRS. Although the baseline National institute of health stroke scale (NIHSS) score and the rate of successful recanalization was not significantly different between CRS patients and control group, CRS patients showed more any cerebral hemorrhage after MT (41.2% vs. controls 23.8%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037) and unfavorable functional outcome at 3\u2009months (CRS patients median 3-month mRS score 4, interquartile range [IQR] 2 to 5.25 vs. controls median 3-month mRS score 3, IQR 1 to 4, [\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.026]). In the patients with CRS, elevated serum D-dimer level and higher baseline NIHSS score were independently associated with unfavorable functional outcome at 3\u2009months (adjusted odds ratio [aOR]: 1.524, 95% confidence interval [CI]: 1.043\u20132.226; aOR: 1.264, 95% CI: 1.010\u20131.582, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MT is an appropriate therapeutic treatment for revascularization in CRS patients. However, elevated serum D-dimer levels and higher baseline NIHSS scores were independent predictors of unfavorable outcome. Further research is warranted to evaluate the significance of these predictors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-021-02086-y","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T13:37:11Z","timestamp":1612791431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Effectiveness of mechanical thrombectomy in cancer-related stroke and associated factors with unfavorable outcome"],"prefix":"10.1186","volume":"21","author":[{"given":"Eung-Joon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeonghoon","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Bong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yeong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Woo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,6]]},"reference":[{"issue":"1","key":"2086_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2008.01059.x","volume":"119","author":"W Grisold","year":"2009","unstructured":"Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a review. Acta Neurol Scand. 2009;119(1):1\u201316.","journal-title":"Acta Neurol Scand"},{"key":"2086_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5853\/jos.2019.02278","volume":"22","author":"OY Bang","year":"2020","unstructured":"Bang OY, Chung J-W, Lee MJ, Seo W-K, Kim G-M, Ahn M-J, Investigators O-CS. Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms. J Stroke. 2020;22:1.","journal-title":"J Stroke"},{"issue":"4","key":"2086_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1161\/STROKEAHA.109.571356","volume":"41","author":"SG Kim","year":"2010","unstructured":"Kim SG, Hong JM, Kim HY, Lee J, Chung P-W, Park K-Y, Kim G-M, Lee KH, Chung C-S, Bang OY. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke. 2010;41(4):798\u2013801.","journal-title":"Stroke"},{"issue":"11","key":"2086_CR4","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1080\/01616412.2018.1504179","volume":"40","author":"J-y Wang","year":"2018","unstructured":"Wang J-y, G-j Z, S-x Z, Wang K, Hu X-P, Zhang H, Qu L-D. D-dimer> 2.785 \u03bcg\/ml and multiple infarcts\u2265 3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients. Neurol Res. 2018;40(11):948\u201354.","journal-title":"Neurol Res"},{"issue":"1","key":"2086_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0733-8619(02)00066-X","volume":"21","author":"LR Rogers","year":"2003","unstructured":"Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin. 2003;21(1):167\u201392.","journal-title":"Neurol Clin"},{"issue":"10","key":"2086_CR6","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/cncr.32802","volume":"126","author":"SJ Henley","year":"2020","unstructured":"Henley SJ, Ward EM, Scott S, Ma J, Anderson RN, Firth AU, Thomas CC, Islami F, Weir HK, Lewis DR. Annual report to the nation on the status of Cancer, part I: national cancer statistics. Cancer. 2020;126(10):2225\u201349.","journal-title":"Cancer"},{"issue":"3","key":"2086_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11060-011-0780-5","volume":"107","author":"JJ Graber","year":"2012","unstructured":"Graber JJ, Nayak L, DeAngelis LM. Use of recombinant tissue plasminogen activator in cancer patients with acute stroke. J Neuro-Oncol. 2012;107(3):571\u20133.","journal-title":"J Neuro-Oncol"},{"issue":"12","key":"2086_CR8","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1136\/jnnp.2010.207472","volume":"82","author":"I Casado-Naranjo","year":"2011","unstructured":"Casado-Naranjo I, Calle ML, Falc\u00f3n A, Serrano A, Portilla JC, Ram\u00edrez-Moreno JM. Intravenous thrombolysis for acute stroke in patients with cancer. J Neurol Neurosurg Psychiatry. 2011;82(12):1404\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"2086_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2012.12.008","volume":"325","author":"M Cappellari","year":"2013","unstructured":"Cappellari M, Carletti M, Micheletti N, Tomelleri G, Ajena D, Moretto G, Bovi P. Intravenous alteplase for acute ischemic stroke in patients with current malignant neoplasm. J Neurol Sci. 2013;325(1\u20132):100\u20132.","journal-title":"J Neurol Sci"},{"issue":"8","key":"2086_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S1474-4422(15)00140-4","volume":"14","author":"BC Campbell","year":"2015","unstructured":"Campbell BC, Donnan GA, Lees KR, Hacke W, Khatri P, Hill MD, Goyal M, Mitchell PJ, Saver JL, Diener H-C. Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. Lancet Neurol. 2015;14(8):846\u201354.","journal-title":"Lancet Neurol"},{"issue":"12","key":"2086_CR11","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013418.","journal-title":"Stroke"},{"issue":"9","key":"2086_CR12","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1007\/s00415-019-09416-8","volume":"266","author":"D Lee","year":"2019","unstructured":"Lee D, Lee DH, Suh DC, Kwon HS, Jeong D-E, Kim J-G, Lee J-S, Kim JS, Kang D-W, Jeon S-B. Intra-arterial thrombectomy for acute ischaemic stroke patients with active cancer. J Neurol. 2019;266(9):2286\u201393.","journal-title":"J Neurol"},{"issue":"5","key":"2086_CR13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/1591019918776207","volume":"24","author":"S Jung","year":"2018","unstructured":"Jung S, Jung C, Hyoung Kim J, Se Choi B, Jung Bae Y, Sunwoo L, Geol Woo H, Young Chang J, Joon Kim B, Han M-K. Procedural and clinical outcomes of endovascular recanalization therapy in patients with cancer-related stroke. Interv Neuroradiol. 2018;24(5):520\u20138.","journal-title":"Interv Neuroradiol"},{"issue":"2","key":"2086_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10072-019-04103-y","volume":"41","author":"B-H Cho","year":"2020","unstructured":"Cho B-H, Yoon W, Kim J-T, Choi K-H, Kang K-W, Lee J-H, Cho K-H, Park M-S. Outcomes of endovascular treatment in acute ischemic stroke patients with current malignancy. Neurol Sci. 2020;41(2):379\u201385.","journal-title":"Neurol Sci"},{"issue":"8","key":"2086_CR15","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.05.018","volume":"28","author":"F Sallustio","year":"2019","unstructured":"Sallustio F, Mascolo AP, Marrama F, Koch G, Alemseged F, Davoli A, Da Ros V, Morosetti D, Konda D, Diomedi M. Safety and efficacy of reperfusion therapies for acute ischemic stroke patients with active malignancy. J Stroke Cerebrovasc Dis. 2019;28(8):2287\u201391.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2086_CR16","doi-asserted-by":"publisher","unstructured":"Jeon Y, Baik SH, Jung C, Kim JY, Kim BJ, Kang J, Bae H-J, Kim JH. Mechanical thrombectomy in patients with acute cancer-related stroke: is the stent retriever alone effective? J NeuroInterv Surg. 2020;0:1\u20136. https:\/\/doi.org\/10.1136\/neurintsurg-2020-016144.","DOI":"10.1136\/neurintsurg-2020-016144"},{"key":"2086_CR17","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3389\/fneur.2020.572589","volume":"11","author":"S Oki","year":"2020","unstructured":"Oki S, Kawabori M, Echizenya S, Shimoda Y, Shimbo D, Osanai T, Uchida K, Houkin K. Long-term clinical outcome and prognosis after Thrombectomy in patients with concomitant malignancy. Front Neurol. 2020;11:1188.","journal-title":"Front Neurol"},{"issue":"11","key":"2086_CR18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","volume":"372","author":"BC Campbell","year":"2015","unstructured":"Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009\u201318.","journal-title":"N Engl J Med"},{"issue":"24","key":"2086_CR19","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","volume":"372","author":"JL Saver","year":"2015","unstructured":"Saver JL, Goyal M, Bonafe A, Diener H-C, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285\u201395.","journal-title":"N Engl J Med"},{"issue":"24","key":"2086_CR20","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1503780","volume":"372","author":"TG Jovin","year":"2015","unstructured":"Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Rom\u00e1n L, Serena J, Abilleira S, Rib\u00f3 M. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296\u2013306.","journal-title":"N Engl J Med"},{"issue":"11","key":"2086_CR21","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","volume":"372","author":"M Goyal","year":"2015","unstructured":"Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019\u201330.","journal-title":"N Engl J Med"},{"issue":"9","key":"2086_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044959","volume":"7","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Park JH, Lee M-J, Park YG, Ahn M-J, Bang OY. Clues to occult cancer in patients with ischemic stroke. PLoS One. 2012;7(9):e44959.","journal-title":"PLoS One"},{"issue":"1","key":"2086_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh E 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35\u201341.","journal-title":"Stroke"},{"issue":"5","key":"2086_CR24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"J Van Swieten","year":"1988","unstructured":"Van Swieten J, Koudstaal P, Visser M, Schouten H, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604\u20137.","journal-title":"Stroke"},{"issue":"9","key":"2086_CR25","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3174\/ajnr.A3496","volume":"34","author":"J Fugate","year":"2013","unstructured":"Fugate J, Klunder A, Kallmes DF. What is meant by \u201cTICI\u201d? Am J Neuroradiol. 2013;34(9):1792\u20137.","journal-title":"Am J Neuroradiol"},{"issue":"10","key":"2086_CR26","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","volume":"46","author":"R von Kummer","year":"2015","unstructured":"von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD, Treurniet KM, Majoie CB, Marquering HA, Mazya MV. The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke. 2015;46(10):2981\u20136.","journal-title":"Stroke"},{"issue":"12","key":"2086_CR27","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","volume":"91","author":"JJ Caro","year":"2001","unstructured":"Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systematic, quantitative review. Cancer. 2001;91(12):2214\u201321.","journal-title":"Cancer"},{"issue":"7","key":"2086_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amjmed.2003.12.008","volume":"116","author":"K Knight","year":"2004","unstructured":"Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 2004;116(7):11\u201326.","journal-title":"Am J Med"},{"issue":"05","key":"2086_CR29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1160\/TH08-05-0339","volume":"100","author":"J Trujillo-Santos","year":"2008","unstructured":"Trujillo-Santos J, Di Micco P, Iannuzzo M, Lecumberri R, Guijarro R, Madridano O, Monreal M, Investigators R. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Thromb Haemost. 2008;100(05):905\u201311.","journal-title":"Thromb Haemost"},{"issue":"3","key":"2086_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11060-012-1011-4","volume":"111","author":"J-M Kim","year":"2013","unstructured":"Kim J-M, Jung K-H, Park KH, Lee S-T, Chu K, Roh J-K. Clinical manifestation of cancer related stroke: retrospective case\u2013control study. J Neuro-Oncol. 2013;111(3):295\u2013301.","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"2086_CR31","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.006","volume":"24","author":"D Cocho","year":"2015","unstructured":"Cocho D, Gendre J, Boltes A, Espinosa J, Ricciardi AC, Pons J, Jimenez M, Otermin P. Predictors of occult cancer in acute ischemic stroke patients. J Stroke Cerebrovasc Dis. 2015;24(6):1324\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"2086_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5853\/jos.2014.16.2.91","volume":"16","author":"K Kim","year":"2014","unstructured":"Kim K, Lee J-H. Risk factors and biomarkers of ischemic stroke in cancer patients. J Stroke. 2014;16(2):91.","journal-title":"J Stroke"},{"issue":"4","key":"2086_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/10408363.2011.599831","volume":"48","author":"KH Allin","year":"2011","unstructured":"Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48(4):155\u201370.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"3","key":"2086_CR34","first-page":"779","volume":"54","author":"E Dardiotis","year":"2019","unstructured":"Dardiotis E, Aloizou A-M, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, Libra M, Kyritsis AP, Brotis AG, Aschner M. Cancer-associated stroke: pathophysiology, detection and management. Int J Oncol. 2019;54(3):779\u201396.","journal-title":"Int J Oncol"},{"issue":"12","key":"2086_CR35","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1161\/STROKEAHA.113.003058","volume":"44","author":"SB Murthy","year":"2013","unstructured":"Murthy SB, Karanth S, Shah S, Shastri A, Rao CPV, Bershad EM, Suarez JI. Thrombolysis for acute ischemic stroke in patients with cancer: a population study. Stroke. 2013;44(12):3573\u20136.","journal-title":"Stroke"},{"issue":"6","key":"2086_CR36","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/ijcp.12586","volume":"69","author":"P Sobolewski","year":"2015","unstructured":"Sobolewski P, Brola W, Szczuchniak W, Fudala M, Sobota A. Safety of intravenous thrombolysis for acute ischaemic stroke including concomitant neoplastic disease sufferers\u2013experience from Poland. Int J Clin Pract. 2015;69(6):666\u201373.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"2086_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.beha.2008.12.005","volume":"22","author":"M Levi","year":"2009","unstructured":"Levi M. Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol. 2009;22(1):129\u201336.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"2086_CR38","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.10.022","volume":"23","author":"Y-J Guo","year":"2014","unstructured":"Guo Y-J, Chang M-H, Chen P-L, Lee Y-S, Chang Y-C, Liao Y-C. Predictive value of plasma D-dimer levels for cancer-related stroke: a 3-year retrospective study. J Stroke Cerebrovasc Dis. 2014;23(4):e249\u201354.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"2086_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/ene.13184","volume":"24","author":"KW Nam","year":"2017","unstructured":"Nam KW, Kim CK, Kim T, An S, Demchuk A, Kim Y, Jung S, Han MK, Ko SB, Yoon BW. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer. Eur J Neurol. 2017;24(1):205\u201311.","journal-title":"Eur J Neurol"},{"issue":"1","key":"2086_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12883-019-1386-3","volume":"19","author":"T Yao","year":"2019","unstructured":"Yao T, Tian B-L, Li G, Cui Q, Wang C-F, Zhang Q, Peng B, Gao Y, Zhan Y-Q, Hu D. Elevated plasma D-dimer levels are associated with short-term poor outcome in patients with acute ischemic stroke: a prospective, observational study. BMC Neurol. 2019;19(1):175.","journal-title":"BMC Neurol"},{"issue":"7","key":"2086_CR41","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3174\/ajnr.A3855","volume":"35","author":"M Almekhlafi","year":"2014","unstructured":"Almekhlafi M, Davalos A, Bonafe A, Chapot R, Gralla J, Pereira V, Goyal M. Impact of age and baseline NIHSS scores on clinical outcomes in the mechanical thrombectomy using solitaire FR in acute ischemic stroke study. Am J Neuroradiol. 2014;35(7):1337\u201340.","journal-title":"Am J Neuroradiol"},{"issue":"12","key":"2086_CR42","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1161\/STROKEAHA.109.561431","volume":"40","author":"RG Nogueira","year":"2009","unstructured":"Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the mechanical embolus removal in cerebral ischemia (MERCI) and multi MERCI trials. Stroke. 2009;40(12):3777\u201383.","journal-title":"Stroke"},{"key":"2086_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.wneu.2017.11.076","volume":"110","author":"CJ Griessenauer","year":"2018","unstructured":"Griessenauer CJ, Medin C, Maingard J, Chandra RV, Ng W, Brooks DM, Asadi H, Killer-Oberpfalzer M, Schirmer CM, Moore JM. Endovascular mechanical thrombectomy in large-vessel occlusion ischemic stroke presenting with low national institutes of health stroke scale: systematic review and meta-analysis. World Neurosurg. 2018;110:263\u20139.","journal-title":"World Neurosurg"},{"issue":"1","key":"2086_CR44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.25495","volume":"86","author":"H Park","year":"2019","unstructured":"Park H, Kim J, Ha J, Hwang IG, Song TJ, Yoo J, Ahn SH, Kim K, Kim BM, Kim DJ. Histological features of intracranial thrombi in stroke patients with cancer. Ann Neurol. 2019;86(1):143\u20139.","journal-title":"Ann Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02086-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-021-02086-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02086-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T13:37:49Z","timestamp":1697809069000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02086-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2086"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02086-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,6]]},"assertion":[{"value":"8 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest<b>.<\/b>","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study has been conducted in compliance with the principles of the declaration of Helsinki. The study was approved by the institutional review board (IRB number: 1009\u2013062-332) of Seoul National University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"57"}}